News | December 07, 2023
Dr. Reddy's inks pact with Coya Therapeutics for development of sclerosis drug
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
The company has raised US$4.5 million in funding for its AI operating system
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Subscribe To Our Newsletter & Stay Updated
